Circulating Tumor Cell Count
1 clinical trials · Condition
◉ Watch Circulating Tumor Cell Count
| Record | Firm | Date |
|---|---|---|
| Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells (NCT03070002) | Northwestern University | 2017-10-19 |
Track Circulating Tumor Cell Count automatically
Every clearance here is in the API, with alerts when new ones post.